Extreme hypereosinophilia in sclerosing cholangitis [3]

Internal Medicine Journal

Volumn 33, Issue 3, 2003, Pages 134-136

  Thurlow, P J ^a   Marshall, A W ^a  

^a AUSTIN HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CEFALEXIN; CIPROFLOXACIN; MESALAZINE; SALAZOSULFAPYRIDINE;

ADULT; BLOOD CELL COUNT; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; EOSINOPHIL; FEMALE; HUMAN; HYPEREOSINOPHILIA; LETTER; LIVER FUNCTION TEST; MEDICAL EXAMINATION; PRIORITY JOURNAL; SCLEROSING CHOLANGITIS; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CHOLANGITIS, SCLEROSING; EOSINOPHILIA; FEMALE; GALLSTONES; HUMANS; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0037344956     PISSN: 14440903     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1445-5994.2003.00363.x     Document Type: Letter

References (8)

1. Wright R, Truelove SC. Circulating and tissue eosinophils in ulcerative colitis. Am J Dig Dis 1966; 11: 831-46.
2. Wiesner RH, La Russo NF. Clinicopathologic features of syndrome of primary sclerosing cholangitis. Gastroenterology 1980; 79: 200-6.
3. Shrumpf E, Elgjo K, Fusa O, Gjone E, Kolmannskogf F, Ritland S. Sclerosing cholangitis in ulcerative colitis. Scand J Gastroenterol 1980; 15: 689-97.
4. Scheurlen M, Mork H, Weber P. HES resembling chronic inflammatory bowel disease with primary sclerosing cholangitis. J Clin Gastroenterol 1992; 14: 59-63.
5. Sherlock S, Dooley J. Sclerosing cholangitis. In: Sherlock S, Dooley J, eds. Diseases of the Liver and Biliary System. Oxford: Blackwell Scientific Publications; 1993; 249-59.
6. Parillo JE, Fauci AS, Wolff SM. Therapy of the hyper eosinophilic syndrome. Ann Intern Med 1978; 89: 167-72.
7. Longworth DL, Weller PF. Hyperinfection syndrome with strongyloidiasis. In: Remington JS, Swartz MN, eds. Current Clinical Topics in Infectious Diseases. New York: McGraw-Hill; 1986; 1-26.
8. Mitter NS, Weiskopf RW. Unusual chromosome 7 abberations in a case of eosinophilic myeloproliferative syndrome. Cancer Genet Cytogenetics 1987; 26: 209-12.